Blog

Phase 1 Trial Assessing Stem Cell Therapy Recruiting Alzheimer’s Patients in Florida – Alzheimer’s News Today


Alzheimer’s News Today

Phase 1 Trial Assessing Stem Cell Therapy Recruiting Alzheimer's Patients in Florida
Alzheimer’s News Today
A Phase 1 trial to evaluate the safety and effectiveness of Longeveron's allogeneic mesenchymal stem cells (LMSCs) in patients with Alzheimer's disease is currently looking for participants, the biopharmaceutical company announced. Eligible

2018-06-01 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.